What is NDC 50742-283?

50742-283 is the product NDC for Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride, Bismuth subcitrate potassium 140 mg/1 + 2 more ingredients capsule, listed with the FDA by Ingenus Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride.

What is the active ingredient?

Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride.

Ingenus Pharmaceuticals, LLC, NDC labeler code 50742. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

NDC 50742-283

NDC codes

FDA NDC Directory

Product NDC (as listed)50742-283Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50742-0283Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50742-283-13	5074202831350742028313	120 CAPSULE in 1 CARTON (50742-283-13)Marketed from Jul 4, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride
Generic name (nonproprietary): bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride
Active ingredients: Bismuth subcitrate potassium — 140 mg/1Metronidazole — 125 mg/1Tetracycline hydrochloride — 125 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Ingenus Pharmaceuticals, LLCNDC labeler code 50742
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217511
Marketing start: Jul 4, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Bismuth (Chemical structure)Nitroimidazoles (Chemical structure)Tetracyclines (Chemical structure)
Identifiers: Product ID 50742-283_6842c7a1-52e9-4047-81e1-22da3ec35505SPL ID 6842c7a1-52e9-4047-81e1-22da3ec35505SPL set ID 4c7f024d-ba26-43cf-a36f-597e2168cd9fRxCUI 1294619UNII R3O80H60KX, 140QMO216E, P6R62377KV
Pharmacologic class: Bismuth; Nitroimidazole Antimicrobial; Tetracycline-class Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450742028313 followed by a unit qualifier and the quantity

Package 50742-0283-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 11, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsule is a combination of metronidazole, a nitroimidazole antimicrobial, tetracycline, - a tetracycline class antimicrobial and bismuth subcitrate potassium, indicated for use, in combination with omeprazole, for the treatment of patients with Helicobacter pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate H. pylori. ( 1.1 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules and other antibacterial drugs, bismuth subcitrate potassium, metronidazo…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50742-283

What is NDC 50742-283?: 50742-283 is the product NDC for Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride, Bismuth subcitrate potassium 140 mg/1 + 2 more ingredients capsule, listed with the FDA by Ingenus Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride.
What is the active ingredient?: Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride.
Who is the labeler?: Ingenus Pharmaceuticals, LLC, NDC labeler code 50742. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride NDC 50742-283